Cooperative clinical studies of hyperthermia using a capacitive type heating device GHT-RF8(Greenytherm).
- Author:
John J K LOH
1
;
Jin Sil SEONG
;
Chang Ok SUH
;
Gwi Eon KIM
;
Sung Sil CHU
;
Kyung Ran PAK
;
Chang Geol LEE
;
Byung Soo KIM
;
Soo Gon KIM
;
David J SEEL
Author Information
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords: Hyperthermia; capacitive heating; deep heating; GHT-RF8 (Greenytherm)
- MeSH: Adolescent; Adult; Aged; Equipment Design; Female; Heating/*instrumentation; Human; Hyperthermia, Induced/adverse effects/*instrumentation; Male; Middle Age; Neoplasms/radionuclide imaging/therapy; Support, Non-U.S. Gov't; Tomography, X-Ray Computed
- From:Yonsei Medical Journal 1989;30(1):72-80
- CountryRepublic of Korea
- Language:English
- Abstract: Yonsei Cancer Center developed an RF(Radiofrequency) capacitive type heating device, GHT-RF8(Greenytherm) in cooperation with Green Cross Medical Corp., Korea in 1986 for the first time in Korea. Cooperative clinical studies of hyperthermia for the treatment of cancer using GHT-RF8 were conducted by Yonsei Cancer Center in collaboration with the Presbyterian Medical Center, Chonju, Korea. A total of forty patients with various histologically proven malignant tumors, including superficial (N = 13) and deep-seated tumors (N = 27), were treated with this newly developed heating device in conjunction with radiotherapy (N = 38) or chemotherapy (N = 2) at two different institutes between October 1986 and September 1987. These patients were locally far advanced or recurrent cases and considered to be refractory to conventional cancer treatment modalities. Radiotherapy was given in 200cGy per day, five times a week fractionations with a total tumor dose of 50-60Gy in 5-6 weeks. Within an hour after radiotherapy, the RF capacitive type of hyperthermia was given two times a week for a total of 4-10 treatment sessions and an attempt was made to maintain the tumor temperature at 41-45 degrees C for 30-60 minutes. Of forty patients treated, 14 patients with deep-seated tumors showed complete response and 20 patients showed partial response. The overall response rate was 85% (34 out of 40 patients) and only 6 patients showed no response. Complications from this treatment were mainly burns, superficial first degree burn in 2 cases, second degree in 4 cases and subcutaneous fat necrosis was observed in 2 cases.
